Clinical Predictors of Steroid-induced Initial Exacerbation in Myasthenia Gravis.
- Author:
Jong Seok BAE
1
;
Byoung Joon KIM
;
Dae Hyun KIM
Author Information
1. Department of Neurology, Seoul Medical Center, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Myasthenia gravis;
Steroid;
Exacerbation;
Predictor
- MeSH:
Body Weight;
Hospitalization;
Humans;
Logistic Models;
Myasthenia Gravis*;
Neurologic Manifestations;
Prednisone
- From:Journal of the Korean Neurological Association
2005;23(4):478-483
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The use of prednisone in the treatment of myasthenia gravis (MG) has been required circumspection because of its tendency to produce exacerbations of weakness in the early stages of treatment, often requiring critical management. However, factors influencing the exacerbation has not been defined well. The purpose of this study was to evaluate the clinical factors predicting the exacerbation by prednisone in the early stage of treatment in MG. METHODS: Fifty five patients, first-ever prescribed high dose prednsone (40-80 mg) during hospitalization in Samsung Medical Center were included. Prednisone induced exacerbation was defined as significant exacerbation of objective neurologic signs of MG within 4 weeks after prednisone addition by utilizing Myasthnia gravis Severity Scale (MSS). We investigate the differences between the exacerbated and nonexacerbated groups in the clinical, laboratory and electrophysiological features. RESULTS: Twenty three patients (42%) experienced definite exacerbation after prednisone treatment. Old age, presence of bulbar symptom, and severe neurologic finding reflected by MSS score were significant predictors of prednisone induced exacerbation in multivariate logistic regression analysis. Higher prednisone dosage per body weight (Kg) was neither a significant predictor of exacerbation nor related with the early improvement in bivariate correlation. CONCLUSIONS: Prednisone induced exacerbation in MG is a frequent challenging problem to clinician. Clinicans should keep in mind the possibility of exacerbation of MG when prescribing prednisone especially, to old, bulbar dominant, severe and disable myasthenic patients.
